What does CUSIP 77313F106 represent in this 13F holders report?

CUSIP 77313F106 is the security identifier for RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in Q3 2023?

174 institutional investors reported RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock for Q3 2023. Use the holders table for investor-level position and value details.

ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / Common Stock
Total 13F shares: 89,401,055
Total 13F value: $1,831,770,744
Share change: +12,407,922
Put/Call ratio: 13%
SEC-reported price per share: $20.49
Number of holders: 174
Value change: +$255,347,743
Number of buys: 104
Number of sells: 60
Shares outstanding: 109,299,832

Security key

77313F106

Report period

Q3 2023

Institutions

174

Top holders

RCKT full security history Ownership snapshot Full 13F holder table ROCKET PHARMACEUTICALS, INC. SEC filings ROCKET PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

WELLINGTON MANAGEMENT GRO...

Disclosed value leader

WELLINGTON MANAGEMENT GRO...

Comparable rows

15/15

Latest evidence

30 Jun 2023

13F Lead comparable stake: 4.7% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 4.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.

Comparable ownership Top 5

WELLINGTON MANAGEMENT GROUP LLP 4.7%

BlackRock Finance, Inc. 4.7%

VANGUARD GROUP INC 4.2%

MAVERICK CAPITAL LTD 4%

WESTFIELD CAPITAL MANAGEMENT CO LP 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	4.7%	$102,180,621 5,142,457 shares	—	30 Jun 2023
BlackRock Finance, Inc.	13F Company 13F	4.7%	$102,048,485 5,135,807 shares	—	30 Jun 2023
VANGUARD GROUP INC	13F Company 13F	4.2%	$91,400,569 4,599,928 shares	—	30 Jun 2023
MAVERICK CAPITAL LTD	13F Company 13F	4%	$87,030,004 4,379,970 shares	—	30 Jun 2023
WESTFIELD CAPITAL MANAGEMENT CO LP	13F Company 13F	3.3%	$72,640,488 3,655,787 shares	—	30 Jun 2023
STATE STREET CORP	13F Company 13F	2.9%	$63,157,272 3,178,524 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

174

89,401,055

Rows available

174

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

162

Q3 2023 holders

174

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %